A Chromophobe Adenoma is a type of non-cancerous (benign) growth in the pituitary gland, which is a small gland at the base of the brain. It's called 'chromophobe' because the cells in the tumor don't stain the way normal pituitary cells do. This type of tumor is usually slow-growing and doesn't typically cause major problems, but it can sometimes affect hormone levels.
Every report comes from a Lived member, sent anonymously.
Have you had Pituitary Removal for Chromophobe Adenoma?
A chromophobe adenoma is a benign (noncancerous) tumor of the pituitary, the pea-sized gland at the base of the brain that makes hormones controlling growth, metabolism, reproduction and the body's response to stress. The name comes from the laboratory. When tumor tissue is stained and viewed under a microscope, these cells take up little of the standard dyes and look pale, which pathologists describe as chromophobe, meaning "color-avoiding." That label describes how the cells look, not how the tumor behaves. Many tumors with this appearance are nonfunctioning, meaning they do not release enough extra hormone to cause symptoms, but some prolactin-producing tumors and other types look the same way. Doctors now classify pituitary tumors mainly by which hormones they make and which cell family they come from, so you may also see the same tumor called a nonfunctioning pituitary adenoma, a gonadotroph adenoma or a pituitary neuroendocrine tumor (PitNET). When a nonfunctioning tumor causes problems, it is usually because of its size. A larger tumor can cause headaches, press on the nerves that carry vision, causing gradual loss of side vision, or squeeze the normal pituitary so it makes too little of one or more hormones. Most pituitary tumors grow slowly and do not spread, and many small ones never cause trouble and are found only by chance on a scan done for another reason.
A pituitary adenoma forms when cells in the gland grow and divide without their usual controls. For most people no cause is found, and nothing in daily life is known to bring one on. Pituitary adenomas are common, and the great majority stay small and harmless for life. A small share are linked to inherited conditions. Multiple endocrine neoplasia type 1 (MEN1) and a few other rare inherited syndromes raise the risk of pituitary tumors. MEN1 also causes tumors in other hormone glands, such as the parathyroid glands and the pancreas, so a personal or family history of tumors in several glands is worth raising with your doctor. Having one of these conditions raises risk; it does not mean a tumor will develop.
A pituitary adenoma is usually suspected because of headaches, vision changes or hormone symptoms, or it turns up on a brain scan done for something else. An MRI (magnetic resonance imaging) scan of the pituitary, usually with a contrast dye injected into a vein, shows the tumor's size and whether it presses on the nerves that carry vision or grows into nearby spaces. A tumor smaller than 1 centimeter is called a microadenoma; one that is 1 centimeter or larger is a macroadenoma. Macroadenomas are more likely to affect vision and hormone levels. Blood tests check each hormone system the pituitary controls, including cortisol, thyroid hormone, sex hormones and growth hormone activity. They answer two separate questions: whether the tumor is making too much of a hormone, which would change treatment, and whether the normal gland is now making too little. Prolactin is always measured. A mildly raised prolactin is common with nonfunctioning tumors, because pressure on the stalk that connects the pituitary to the brain can lift it, so the result is interpreted together with the tumor's size. An eye examination includes a visual field test, which maps how far you can see to each side while looking straight ahead. Pressure from a pituitary tumor typically narrows side vision first. This test also sets a baseline for judging whether vision improves after treatment. The chromophobe label, and the precise tumor type, are confirmed only after tissue has been removed, usually during surgery, and examined under a microscope with hormone stains.
Treatment depends on whether the tumor is causing problems and what kind it turns out to be. Some tumors that cause no symptoms, and tumors in people for whom surgery would be risky, are monitored with repeat MRI scans, hormone tests and vision checks. Monitoring is an active plan rather than a guarantee that nothing will change: in one study of untreated nonfunctioning tumors, about half grew over time and about one in five people eventually needed surgery. For a nonfunctioning tumor that is pressing on the vision nerves or causing other symptoms, surgery is the preferred first treatment. Most operations are done through the nose (transsphenoidal surgery), often using an endoscope, a thin tube with a camera, so no opening in the skull is needed. Surgery removes all or most of the tumor and relieves pressure right away. Vision improves in most people whose sight was affected (about 75% to 91% in published studies), although recovery is less likely in older people and when vision loss has lasted more than about four months. Low hormone levels improve after surgery in roughly a third to a half of people. The most common problems after surgery include a leak of the fluid that surrounds the brain and a shortage of the hormone that tells the kidneys to hold on to water (diabetes insipidus), which causes heavy thirst and large amounts of urine. New hormone shortages can also occur. Some tumor is left behind in about 10% to 36% of people. Leftover or returning tumor may be treated with another operation or with radiation, including stereotactic radiosurgery, which aims a concentrated dose precisely at the tumor. Medicines that work well for some hormone-producing tumors have given inconsistent results for nonfunctioning ones and are not a standard first choice. If testing shows the tumor makes prolactin, the approach is different: medicine is usually tried first, typically cabergoline, a dopamine agonist that lowers prolactin and shrinks the tumor, and surgery is reserved for tumors that do not respond or for people who cannot take the medicine. Whatever the tumor type, hormones the pituitary can no longer make in adequate amounts are replaced with medicines, such as hydrocortisone to replace cortisol and thyroid hormone tablets. Doses are adjusted with care, because taking more replacement than the body needs carries its own long-term risks to the heart, metabolism and bones. The opposite matters too: people taking hydrocortisone usually need a higher dose during significant illness, injury or surgery, so ask your endocrinologist for a written sick-day plan and carry a medical alert card or bracelet that says you have adrenal insufficiency.
A chromophobe adenoma is usually managed over years rather than fixed in a single step. After surgery, the first MRI is typically done at least three months later, once healing has settled, so that it shows how much tumor remains. Scans, hormone tests and vision checks then continue long term to catch regrowth and changes in pituitary function. There is no agreed schedule for how often or for how long; it depends on how much tumor remains and which treatments you have had. For people who need hormone replacement, it becomes part of the daily routine, with periodic blood tests and dose changes. Symptoms of hormone shortage, such as low energy, low sex drive or missed periods, often ease once levels are corrected, and in some people the gland's own function recovers after surgery. Hormone shortages can affect fertility, so anyone hoping to become pregnant should plan ahead with their endocrinologist, who will usually adjust replacement before conception. Vision that was affected often improves after surgery, but some loss can remain, particularly when it had been present for a long time. Care usually involves a team that includes an endocrinologist (a hormone specialist), a neurosurgeon and an eye specialist, and sometimes a radiation specialist.
See a doctor if you have persistent headaches together with changes in your vision, or signs that pituitary hormones may be low, such as periods becoming irregular or stopping, reduced sex drive, erection problems, unexplained loss of body hair, or slowed growth in a child. Contact your care team promptly if you notice your side vision narrowing, for example bumping into things or missing objects on one side, because the chance of recovery falls the longer vision loss goes on. After pituitary surgery, call your surgical team about extreme thirst with large amounts of urine, or clear, watery fluid dripping from your nose. A sudden, severe headache, especially with sudden loss of vision, double vision, vomiting or confusion, can mean bleeding into the tumor or loss of its blood supply (pituitary apoplexy). This can happen even in people who did not know they had a tumor. It is a medical emergency: call 911 or go to an emergency department right away, because it can cause a dangerous shortage of cortisol and threaten vision, and it needs urgent hormone treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Chromophobe Adenoma is like, what's helped you, or ask the community a question.